Interleukin-6 production and deregulation of the hypothalamic-pituitary- adrenal axis in patients with major depressive disorders

Endocrine

Volumn 30, Issue 3, 2006, Pages 371-376

  Humphreys, Derek ^a   Schlesinger, Liana ^a   Lopez, Marcelo ^a   Araya, A Verönica ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

HPA axis; IL 6; LPS; Major depressive disorders

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MAJOR DEPRESSION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 34347341736     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-006-0016-1     Document Type: Article

References (42)

1. Chrousos, G. P. and Gold, P. W. (1992). JAMA 267, 1244-1252.
2. Holsboer, F. and Barden, N. (1996). Endocr. Rev. 17, 187-205.
3. Plotsky, P., Owens, M., and Nemeroff, C. (1998). Psychiatric Clin. North. Am. 21, 293-307.
4. Musselman, D. and Nemeroff, C. (1995). Endocrinologist 5, 91-96.
5. Gold, P., Licinio, J., Wong, M. L., and Chrousos, P. (1995). Ann. N.Y. Acad. Sci. 771, 716-729.
6. Carroll, B. J., Feinberg, M., Greden, J. F., et al. (1981). Arch. Gen. Psychiatry 38, 15-22.
7. Irwin, M. (1994). Adv. Neuroimmunol. 4, 29-36.
8. Kathol, R., Jaeckle, R., Lopez, J., and Meller, W. (1989). Br. J. Psychiatry 155, 468-478.
9. Holsboer, F., von Bardeleben, U., Gerken, A., Stalla, G. K., and Muller, O. A. (1984). N. Engl. J. Med. 311, 1127-1136.
10. Felten, D. L., Felten, S. Y., Bellinger, D. L., et al. (1987). Immunol. Rev. 100, 225-260.
11. Arborelius, L., Owens, M. J., Plotsky, P. M., and Nemeroff, C. B. (1999). J. Endocrinol. 160, 1-12.
12. Cacioppo, J. T., Berntson, G. G., Malarkey, W. B., et al. (1998). Ann. N.Y. Acad. Sci. 840, 664-673.
13. Schiepers, O. J., Wichers, M. C., and Maes, M. (2005). Prog. Neuropsychopharmacol. Biol. Psychiat. 29, 201-217.
14. Ader, R., Cohen, N., and Felten, D. (1995). Lancet 345, 99-103.
15. Haddad, J. J., Saadé, N. E., and Safieh-Garabedian, B. (2002). J. Neuroimmunol. 133, 1-19.
16. Path, G., Scherbaum, W. A., and Bornstain, S. R. (2000). Eur. J. Clin. Invest. 30, 91-95.
17. Maes, M., Song, C., Lin, A., et al. (1999). Neuropsychopharmacol. 20, 370-379.
18. Connor, T. J. and Leonard, B. E. (1998). Life Sci. 62, 583-594.
19. Maes, M., Meltzer, H. Y., Bosmans, E., et al. (1995). J. Affect. Dissord. 34, 301-309.
20. Sluzewska, A., Rybakowski, J., Laciak, M., Mackiewicz, A., Sobieska, M., and Wictorowicz, K. (1995). Ann. N.Y. Acad. Sci. 762, 474-482.
21. American Psychiatric Association. (2000). Diagnostical and statistical manual of mental disorders. 4th ed. APA, Washington DC.
22. Hamilton, M. (1996). Br. J. Soc. Clin. Psychol. 6, 278-296.
23. Montgomery, S. A. and Asberg, M. (1979). Br. J. Psychiatry 134, 382-389.
24. Calfa, G., Kademian, S., Ceschin, D., Vega, G., Rabinovich, G. A., and Volosin, M. (2003). Psychoneuroendocrinology 28, 687-701.
25. Caroll, B. J., Martin, F. I., and Davies, B. (1968). Br. Med. J. 613, 285-287.
26. Chrousos, G. P., Schulte, H. M., Oldfield, E. H., Gold, P. W., Cutler, G. B., and Loriaux, L. (1984). N. Engl. J. Med. 310, 622-626.
27. Arnaldi, G., Angeli, A., Atkinson, A. B., et al. (2003). J. Clin. Endocrinol. Metab. 88, 5593-5602.
28. Katz, J. R., Taylor, N. F., Goodrick, S., Perry, L., Yudkin, J. S., and Coppack, S. W. (2000). Int. J. Obes. Relat. Metab. Disord. 24, 246-251.
29. Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K., and Chrousos, G. P. (1997). J. Clin. Endocrinol. Metab. 82, 1313-1316.
30. Straub, R. H., Hense, H. W., Andus, T., Scholmerich, J., Riegger, G. A., and Schunkert, H. (2000). J. Clin. Endocrinol. Metab. 85, 1340-1344.
31. Maes, M., Calabrese, J., and Meltzer, H. Y. (1994). Prog. Neuropsychopharmacol. Biol. Psychiat. 18, 503-517.
32. Strickland, P. L., Deakin, J. F., Percival, C., Dixon, J., Gater, R. A., and Goldberg, D. P. (2002). Br. J. Psychiatry 180, 168-173.
33. Zyah, I. S., Ko, H. C., and Lu, R. B. (1998). Biol. Psychiatry 44, 648-685.
34. Yanovski, J. A., Yanovski, S. Z., Friedman, T. C., et al. (1996). J. Clin. Endocrinol. Metab. 81, 3307-3311.
35. Marques-Deak, A. H., Neto, F. L., Dominguez, W. V., et al. (2005). J. Psychiatr. Res. 41, 152-159.
36. Kagaya, A., Kugaya, A., Takebayashi, M., et al. (2001). Neuropsychobiology 43, 59-62.
37. Kubera, M., Kenis, G., Bosmans, E., et al. (2000). Pol. J. Pharmacol. 52, 237-241.
38. Maes, M., Scharpe, S., Meltzer, H. Y., et al. (1993). Psychiatry Res. 49, 11-27.
39. Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., and Kirchner, H. (1995). Scand. J. Immunol. 41, 534-538.
40. Zorrilla, E. P., Luborsky, L., McKay, J. R., et al. (2001). Brain Behav. Immunity 15, 199-226.
41. Rohleder, N., Wolf, J. M., Piel, M., and Kirschbaum, C. (2003). Psychoneuroendocrinology 28, 261
42. Papanicolaou, D. A., Petrides, J. S., Tsigos, C., et al. (1996). Am. J. Physiol. 271, 601-605.